Tomoaki Akagi

Effect of long-term cryopreservation at −80 °C on the viability and recovery of peripheral blood stem cells

Tomoaki Akagi

jp (code pays fourni par la source)

Effect of long-term cryopreservation at −80 °C on the viability and recovery of peripheral blood stem cells

Tomoaki Akagi

jp (code pays fourni par la source)

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis

Katsuto Takenaka, Tomoki Ito, Norio Komatsu, Hiroki Yamaguchi et autres

jp (code pays fourni par la source)

Authors’ Reply to Noguchi et al. Comment on: “Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database”

Toshiaki Sakamoto, Hirotaka Miyamoto, Junya Hashizume, Hayato Akamatsu et autres

jp (code pays fourni par la source)

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)

Tomoaki Akagi, Hirofumi Hamano, Hirotaka Miyamoto, Tatsuaki Takeda et autres

jp (code pays fourni par la source)

Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database

Toshiaki Sakamoto, Hirotaka Miyamoto, Junya Hashizume, Hayato Akamatsu et autres

jp (code pays fourni par la source)

Development of a Two-Layered Sheet Formulation of 5-Fluorouracil for Application to Rat’s Livers to Ensure Controlled Release and Local Drug Disposition

Tomoaki Akagi, Yosuke Kariya, Hisashi Hamasaki, Miyako Sakaguchi et autres

jp (code pays fourni par la source)

PB1942 DOES STEPWISE DOSE ESCALATION METHOD OF NILOTINIB FOR CML IMPROVE MR4.5 AND TREATMENT FREE REMISSION?

Ko Mayama, Kyosuke Yamaguchi, Satoshi Yamashita, T. Ebina et autres

jp (code pays fourni par la source)

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma

Yoshihiro Kameoka, Tomoaki Akagi, Kazunori Murai, Hideyoshi Noji et autres

jp (code pays fourni par la source)

Lumbosacral nerve root lesion with malignant lymphoma

Haruo Nishijima, Tomoaki Akagi, Tatsuya Ueno, Tomoya Kon et autres

jp (code pays fourni par la source)

Suspected Pulmonary Infection with Trichoderma longibrachiatum after Allogeneic Stem Cell Transplantation

Tomoaki Akagi, Chizuko Kawamura, Norio Terasawa, Kohei Yamaguchi et autres

jp (code pays fourni par la source)

Preliminary Experience of Yttrium-90 Ibritumomab Tiuxetan in Patients with Low-Grade B Cell Non-Hodgkin Lymphoma

Junichi Yokouchi, Tomoaki Akagi, Toshihiro Iwata, Yui Kudo et autres